OncoTEX Inc.

OncoTEX Inc. is on a mission to transform cancer therapy with TEX Core, a first-in-class oncology drug platform.

[OncoTEX Inc. @OncoTex]

OncoTEX is proud to celebrate the 65th birthday of pioneer chemist and cancer survivor, Professor Jonathan Sessler. Prof Sessler’s Texaphyrin molecules are the prime components of our TEX Core anticancer drug platform, and will someday help save lives. https://t.co/kRRcxqIy2E

[OncoTEX Inc. @OncoTex]

OncoTEX is committed to transforming current cancer treatments to address urgent unmet clinical needs. #WorldCancerDay #CloseTheCareGap

[OncoTEX Inc. @OncoTex]

OncoTEX Inc. is pleased to announce its @ChemSocRev submission discussing how novel gold compounds can activate the immune system to destroy cancer. https://t.co/fbHkWhJqCu

[OncoTEX Inc. @OncoTex]

OncoTEX has made a significant leap in the future of cancer treatment by acquiring a gold compound platform technology, AuraTEX, that helps destroy cancer cells by using the body’s immune system. https://t.co/4c5ZFkXoA4